Sorrento Therapeutics, Inc.

CIK 850261 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sorrento Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 21, 2025SEC STAFF ACTION9999999997-25-000542
Nov 7, 20238-K0001104659-23-115270
Nov 3, 20238-K0001104659-23-114354
Oct 27, 20238-K0001104659-23-112178
Oct 5, 20238-K0001104659-23-107275
Oct 5, 2023SC 13G/A0001104659-23-107269
Oct 5, 202340001104659-23-107259
Sep 26, 2023SC 13D/A0001104659-23-103904
Sep 26, 20238-K0001104659-23-103911
Sep 25, 202340001104659-23-103527
Sep 13, 20238-K0001104659-23-100179
Aug 28, 20238-K0001104659-23-096071
Aug 21, 20238-K0001104659-23-093768
Aug 15, 2023SC 13D/A0001193125-23-212733
Aug 14, 202310-Q0000950170-23-041995
Aug 10, 20238-K0001104659-23-089802
Aug 7, 2023NT 10-Q0000950170-23-039079
Aug 1, 20238-K0001104659-23-085989
Jul 18, 2023POS AM0001104659-23-082080
Jul 13, 20238-K0001104659-23-080534
Jul 10, 20238-K0001104659-23-079246
Jun 21, 2023POS AM0001104659-23-073415
Jun 20, 20238-K0001104659-23-072951
Jun 15, 20238-K0001104659-23-071434
May 19, 20238-K0001104659-23-062384